185 related articles for article (PubMed ID: 7844893)
1. [A trial of setting of the reference intervals of thrombin antithrombin III complex and fibrin.fibrinogen degradation products in pregnant women].
Shizuka R; Amagai H; Kojima J; Imaizumi S; Fukumura Y; Kobayashi I; Takagi T; Ibuki Y
Rinsho Byori; 1994 Nov; 42(11):1194-8. PubMed ID: 7844893
[TBL] [Abstract][Full Text] [Related]
2. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
3. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
[TBL] [Abstract][Full Text] [Related]
4. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
Bombeli T; Raddatz-Mueller P; Fehr J
Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
[TBL] [Abstract][Full Text] [Related]
5. [The clinical significance of thrombin-antithrombin III complex (TAT) and fibrinogen and fibrin degradation products (FDP) levels in ovarian cancer].
Sawaguchi K; Hojo T; Nozaki S; Yabushita H; Noguchi M; Nakanishi M
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jan; 44(1):73-8. PubMed ID: 1541865
[TBL] [Abstract][Full Text] [Related]
6. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
Koh SC; Anandakumar C; Biswas A; Fong YF
Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
[No Abstract] [Full Text] [Related]
7. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes.
Uszyński M
Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):127-31. PubMed ID: 9447363
[TBL] [Abstract][Full Text] [Related]
8. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
Bremme K; Ostlund E; Almqvist I; Heinonen K; Blombäck M
Obstet Gynecol; 1992 Jul; 80(1):132-7. PubMed ID: 1534880
[TBL] [Abstract][Full Text] [Related]
9. Fibrin monomer complex in normal pregnant women: a potential thrombotic marker in pregnancy.
Onishi H; Kaniyu K; Iwashita M; Tanaka A; Watanabe T
Ann Clin Biochem; 2007 Sep; 44(Pt 5):449-54. PubMed ID: 17761030
[TBL] [Abstract][Full Text] [Related]
10. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
11. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
Choi JW; Pai SH
Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
[TBL] [Abstract][Full Text] [Related]
13. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
14. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
15. [Modifications induced on thrombin and plasmin activity by voluntary interruption of pregnancy].
Manoni F; Gessoni G; Antico A; Finesso P; Rossito G; Sartori R
Minerva Ginecol; 1993 May; 45(5):245-50. PubMed ID: 8351063
[TBL] [Abstract][Full Text] [Related]
16. [Changes in fibrinogen, fibrin-fibrinogen degradation products and fibrinolytic activity during pregnancy, labor and the puerperium in pregnant women with chronic hypertension].
Kendić S; Mujezinović O; Muratović H
Med Arh; 2000; 54(1):29-31. PubMed ID: 10872273
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of the hemostasis parameters in the development of preeclampsia.
Ho CH; Yang ZL
Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
[TBL] [Abstract][Full Text] [Related]
19. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
20. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
